Gane E. Safety and Efficacy at 1 year after Switching from Tenofovir Disoproxil Fumurate to Tenofovir Alafenamide in Chronic HBV Patients with Risk Factors for TDF Use. PS-156.
Verhoogd risico op leverziekte en mortaliteit bij hepatitis D-virus
okt 2024 | Hepatitis, Hepatologie, Virale infecties